| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243733C Application of imino alkyl carboxylic acid using for producing percarboxylic acid and producing process |
| 02/28/2006 | US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2006 | US7005445 Protein kinase and phosphatase inhibitors and methods for designing them |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | WO2006020664A2 Ammonolysis process for the preparation of intermediates for dpp iv inhibitors |
| 02/23/2006 | WO2006018846A2 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4h- carbazol-4-one and ondansetron therefrom |
| 02/23/2006 | WO2006018815A1 Piperazine derivatives as adrenergic receptor antagonists |
| 02/23/2006 | WO2005079497A3 Substituted fused bicyclic amines as modulators of chemokine receptor activity |
| 02/23/2006 | WO2005053614A3 Advanced indolinone based protein kinase inhibitors |
| 02/23/2006 | US20060041034 Polyoxo derivatives of bis(pyrimidinylidene)-, bis(indanylidene)-, bis(dioxanylidene)- and bis(pyrazolylidene)- condensates of bisisoindolylidenes, e.g., 3,3'-Bis(1,3-dioxoindan-2-ylidene)-[1,1']biisoindolylidene and 3,3'-Bis(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060041005 Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as CPLA2 inhibitors |
| 02/23/2006 | US20060041004 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
| 02/23/2006 | CA2576952A1 Methods for producing isoindole derivatives |
| 02/23/2006 | CA2576091A1 Indole derivatives comprising an acetylene group as ppar activators |
| 02/23/2006 | CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | CA2575046A1 Oxime ester photoinitiators |
| 02/22/2006 | EP1626964A2 New benzimidazole derivatives |
| 02/22/2006 | EP1626957A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 02/22/2006 | EP1626956A1 A novel process for preparation of indole derivatives |
| 02/22/2006 | EP1626951A1 Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 02/22/2006 | EP1626716A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738816A Substituted indolepyridinium as anti-infective compounds |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738798A Indole derivatives as somatostatin agonists or antagonists |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738614A Methods of using and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 02/22/2006 | CN1738613A Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 02/22/2006 | CN1736985A Growth hormone secretagogues |
| 02/22/2006 | CN1736981A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1736371A Selective androgen receptor modulators and methods of use thereof |
| 02/22/2006 | CN1243003C Aspertoxin P as compound with antineoplastic activity |
| 02/22/2006 | CN1243001C Method of manufacturing sertindole |
| 02/22/2006 | CN1242990C Red light emitted compound used for organic electroluminous device and orgainic electroluminous device using same |
| 02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 02/21/2006 | US7001923 Taxol enhancer compounds |
| 02/21/2006 | US7001536 Organometallic complexes as phosphorescent emitters in organic LEDs |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2239970C Process for preparing optically active compounds |
| 02/21/2006 | CA2065986C 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1h-indoles, intermediates and a process for their preparation, and their use as medicaments |
| 02/16/2006 | WO2006017542A1 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 02/16/2006 | WO2006016657A1 Drug for treating or preventing hcv infection |
| 02/16/2006 | WO2006016600A1 Tartaric acid derivative and high-molecular weight crosslinked matter synthesized by using the derivative |
| 02/16/2006 | WO2006016598A1 Biological low-molecular weight derivative, crosslinked matter and biodegradable and absorbable adhesive material for medical use |
| 02/16/2006 | WO2006016245A1 Muscarinic receptor antagonists |
| 02/16/2006 | WO2005097107A8 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | WO2005002525A3 Cox-2 and faah inhibitors |
| 02/16/2006 | US20060036101 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | US20060036100 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst |
| 02/16/2006 | US20060035967 Novel phthalamide derivatives |
| 02/16/2006 | US20060035956 Indole derivatives comprising an acetylene group |
| 02/16/2006 | US20060035954 Ammonolysis process for the preparation of intermediates for DPP IV inhibitors |
| 02/16/2006 | US20060035941 Calcium salts of indole derived statins |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | DE102004033902A1 New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease |
| 02/16/2006 | CA2576581A1 Substituted indole compounds, their preparation and use in medicaments |
| 02/16/2006 | CA2575736A1 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 02/16/2006 | CA2575618A1 Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 02/15/2006 | EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 02/15/2006 | CN1735613A 稠合杂环化合物 Fused heterocyclic compounds |
| 02/15/2006 | CN1735594A Polymorphs of bicifadine hydrochloride |
| 02/15/2006 | CN1733758A Imide analog compounds and its preparation method |
| 02/15/2006 | CN1733727A Crystalline carvedilol, processes for the manufacture thereof, pharmaceutical compositions and uses thereof |
| 02/15/2006 | CN1733726A N-methylphthalimide preparation process |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733724A Crystalline form of (2R,4R)-monatin potassium salt and sweetener composition containing same |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1241926C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 02/15/2006 | CN1241925C New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998491 For use in oxidation reactions, carboxylation reactions, nitration reactions, sulfonation reactions, coupling reactions |
| 02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | US6998403 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/09/2006 | WO2006015060A2 Isoindoline compounds and methods of their use |
| 02/09/2006 | WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | WO2006014024A1 Therapeutic agent for psychoneurotic disease |
| 02/09/2006 | WO2006013227A2 METHYLAMINE RISKS and TREATMENT WITH N-DERIVATIVES OF HYPERACTIVITY, DEPRESSION AND ALCOHOLISM |
| 02/09/2006 | WO2006013048A1 Indole, indazole or indoline derivatives |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030614 dissolving in a solvent, precipitating crystal form by cooling the solution to about -20C |
| 02/09/2006 | US20060030593 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030544 enzyme inhibitors comprising 5-fluoroindole-2-carboxamide compounds, used for the treatment cancer, psoriasis, artherosclerosis, non-insulin depepndent diabetes, obesity and as immunomodulators |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |